Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Oncogene

• Publication date

  2004-02-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1207259PMID 14647420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RUNX transcription factors as key targets of TGF-β superfamily signaling

  2003cited by this paper
• RUNX transcription factors as key targets of TGF-beta superfamily signaling.

  2003cited by this paper
• Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.

  2002cited by this paper
• TGF-β signaling: positive and negative effects on tumorigenesis

  2002cited by this paper
• Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells

  2002cited by this paper
• Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors.

  2002cited by this paper
• TGF-beta signaling: positive and negative effects on tumorigenesis.

  2002cited by this paper
• The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-β Signaling by Blocking Binding of the Smad Complex to Its Target Sequence*

  2002cited by this paper
• Causal relationship between the loss of RUNX3 expression and gastric cancer.

  2002cited by this paper
• Hereditary aspects of gastric cancer.

  2002cited by this paper
• Human T-cell Lymphotropic Virus Type 1 Tax Inhibits Transforming Growth Factor-β Signaling by Blocking the Association of Smad Proteins with Smad-binding Element*

  2002cited by this paper
• TGF-β signaling in tumor suppression and cancer progression

  2001cited by this paper
• Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts*

  2001cited by this paper
• Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.

  2001cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• Smad Proteins and Hepatocyte Growth Factor Control Parallel Regulatory Pathways That Converge on β1-Integrin To Promote Normal Liver Development

  2001cited by this paper
• Role of transforming growth factor-beta signaling in cancer.

  2000cited by this paper
• Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.

  2000cited by this paper
• Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.

  2000cited by this paper
• Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers

  2000cited by this paper
• Role of Transforming Growth Factor-β Signaling in Cancer

  2000cited by this paper
• Transcriptional control by the TGF‐β/Smad signaling system

  2000cited by this paper
• Role of transforming growth factor beta in human disease.

  2000cited by this paper
• Molecular mechanisms of inactivation of TGF-β receptors during carcinogenesis

  2000cited by this paper
• Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β

  1999cited by this paper
• Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein

  1999cited by this paper
• Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-β-induced cell cycle arrest of gastric carcinoma cells

  1999cited by this paper
• Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction

  1999cited by this paper
• MDS1/EVI1 enhances TGF-β1 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-β1

  1999cited by this paper
• Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas.

  1999cited by this paper
• Truncation of the TGF-β type II receptor gene results in insensitivity to TGF-β in human gastric cancer cells

  1999cited by this paper
• Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.

  1999cited by this paper
• The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling.

  1999cited by this paper
• c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads*

  1999cited by this paper
• Interaction and Functional Cooperation of PEBP2/CBF with Smads

  1999cited by this paper
• No mutations of the Smad2 gene in human sporadic gastric carcinomas.

  1999cited by this paper
• The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene.

  1999cited by this paper
• Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer Cells*

  1999influential reference
• DPC4/SMAD4 gene alterations in human cancer, and their functional implications.

  1999cited by this paper
• Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein

  1999cited by this paper
• Somatic alterations of the SMAD-2 gene in human colorectal cancers.

  1998cited by this paper
• Transcriptional Activators of TGF-β Responses: Smads

  1998cited by this paper
• Human Smad3 and Smad4 are sequence-specific transcription activators.

  1998cited by this paper
• TGF-beta signal transduction.

  1998cited by this paper
• E-cadherin germline mutations in familial gastric cancer

  1998cited by this paper
• Smad3 mutant mice develop metastatic colorectal cancer.

  1998cited by this paper
• The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3

  1998cited by this paper
• Smads: transcriptional activators of TGF-beta responses.

  1998cited by this paper
• Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

  1998cited by this paper
• The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3.

  1998cited by this paper
• Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers.

  1998cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• Regulation of differentiation by TFG-β

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• How tumors become angiogenic.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• Regulation of differentiation by TGF-beta.

  1996cited by this paper
• Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

  1995cited by this paper
• A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

  1995cited by this paper
• TGF-β related genes in development

  1994cited by this paper
• Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.

  1994cited by this paper
• TGF-beta related genes in development.

  1994cited by this paper
• Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness.

  1994cited by this paper
• Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

  1994cited by this paper
• Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.

  1994cited by this paper
• Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

  1991cited by this paper
• E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells

  1991cited by this paper
• Peptide Growth Factors and Their Receptors I

  1990cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper

• P53-Independent G1-Cell Cycle Arrest Increases SARS-CoV-2 RNA Replication

  2024cites this paper
• Receptor-activated transcription factors and beyond: multiple modes of Smad2/3-dependent transmission of TGF-β signaling.

  2024cites this paper
• Proteomic analysis of extracellular vesicles derived from canine mammary tumour cell lines identifies protein signatures specific for disease state

  2024cites this paper
• Gastric cancer with brain metastasis: from molecular characteristics and treatment

  2024cites this paper
• Melatonin targeting non-coding RNAs in cancer: Focus on mechanisms and potential therapeutic targets.

  2023cites this paper
• Identification of common factors among fibrosarcoma, rhabdomyosarcoma, and osteosarcoma by network analysis

  2023cites this paper
• TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases

  2021cites this paper
• Clinico-pathological and transcriptomic analysis of radiation-induced lung injury in non-human primates.

  2021cites this paper
• APIR: a universal FDR-control framework for boosting peptide identification power by aggregating multiple proteomics database search algorithms

  2021cites this paper
• APIR: Aggregating Universal Proteomics Database Search Algorithms for Peptide Identification with FDR Control

  2021cites this paper
• Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review).

  2020cites this paper
• The Relationship Between Single Nucleotide Polymorphisms of SMAD3/SMAD6 and Risk of Esophageal Squamous Cell Carcinoma in Chinese Population

  2020cites this paper
• SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer

  2020cites this paper
• Overexpression of c‐Ski promotes cell proliferation, invasion and migration of gastric cancer associated fibroblasts

  2019cites this paper
• microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma

  2019cites this paper
• The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma

  2018cites this paper
• PD-1 and cancer: molecular mechanisms and polymorphisms

  2018cites this paper
• Melatonin Inhibits the Proliferation of Gastric Cancer Cells Through Regulating the miR-16-5p-Smad3 Pathway

  2018cites this paper
• Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon‐independent manner

  2017cites this paper
• Genetic variants of cell cycle pathway genes predict disease‐free survival of hepatocellular carcinoma

  2017cites this paper
• FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis

  2017cites this paper
• Prepubertal Di-n-Butyl Phthalate Exposure Alters Sertoli and Leydig Cell Function and Lowers Bone Density in Adult Male Mice.

  2016cites this paper
• TGF-β signaling in liver and gastrointestinal cancers.

  2016cites this paper
• Carcinogen 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis is accelerated in Smad3 heterozygous mice compared to Smad3 wild type mice

  2016cites this paper
• Mechanism analysis of colorectal cancer according to the microRNA expression profile

  2016cites this paper
• Establishment of a gastric cancer subline with high metastatic potential using a novel microfluidic system

  2016cites this paper
• miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway

  2016cites this paper
• Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.

  2016cites this paper
• Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

  2016cites this paper
• Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine

  2016cites this paper
• Dichotomous roles of TGF-β in human cancer.

  2016cites this paper
• Hsa-miR-590-5p Interaction with SMAD3 Transcript Supports Its Regulatory Effect on The TGFβ Signaling Pathway

  2016cites this paper
• RUNX3-mediated up-regulation of miR-29b suppresses the proliferation and migration of gastric cancer cells by targeting KDM2A.

  2016cites this paper
• miR-145 inhibits invasion and metastasis by directly targeting Smad3 in nasopharyngeal cancer

  2015cites this paper
• miR-145 regulates chemoresistance in hepatocellular carcinoma via epithelial mesenchymal transition.

  2015cites this paper
• Molecular Mechanisms in Gastric Carcinogenesis

  2015cites this paper
• Transforming growth factor-β, MAPK and Wnt signaling interactions in colorectal cancer

  2015cites this paper
• STAT3 selectively interacts with Smad3 to antagonize TGF-β signaling

  2015cites this paper
• Protein-Protein Interaction Network could reveal the relationship between the breast and colon cancer

  2015cites this paper
• Improving DNA Quality using FFPE tissues for Array Comparative Genomic Hybridization to find Single Nucleotide Polymorphisms (SNPs) in Melanoma

  2015cites this paper
• Republished: Tracing PAKs from GI inflammation to cancer

  2014cites this paper
• Tracing PAKs from GI inflammation to cancer

  2014cites this paper
• The Smad7–Skp2 complex orchestrates Myc stability, impacting on the cytostatic effect of TGF-&bgr;

  2014cites this paper
• Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis

  2014cites this paper
• [SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases].

  2014cites this paper
• miR‐193b promotes cell proliferation by targeting Smad3 in human glioma

  2014cites this paper
• Modulation of paracrine interactions between prostate cancer cells and bone marrow stromal cells by transforming growth factor-beta signaling during colonization of bone

  2014cites this paper
• Suppression of Premature Senescence and Promotion of Metastatic Transformation: Role of Reduced TGF-Beta Signaling in Human Cancer Progression

  2014cites this paper
• Tumor Dormancy, Quiescence, and Senescence, Volume 2

  2014cites this paper
• Understanding the Role of Smad4 in Intestinal Homeostasis and Tumorigenesis

  2014cites this paper
• Smad3 and Smad3 Phosphoisoforms Are Prognostic Markers of Gastric Carcinoma

  2013cites this paper
• The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.

  2013cites this paper
• Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors

  2013cites this paper
• Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells.

  2013cites this paper
• Erratum to: Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma

  2013cites this paper
• Betaglycan Alters NF (cid:1) B-TGF (cid:2) 2 Cross Talk to Reduce Survival of Human Granulosa Tumor Cells

  2013cites this paper
• Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma

  2013cites this paper
• High levels of secreted frizzled-related protein 1 correlate with poor prognosis and promote tumourigenesis in gastric cancer.

  2013cites this paper
• The role of PTPRK and PTPRM in prostate and breast cancer

  2013cites this paper
• TGF-ß Signaling Pathway and Colorectal Cancer

  2013cites this paper
• TGF-β signalling and its role in cancer progression and metastasis

  2012cites this paper
• Signaling Mechanisms of Transforming Growth Factor-β (TGF-β) in Cancer: TGF-β Induces Apoptosis in Lung Cells by a Smad-Dependent Mechanism

  2012cites this paper
• TGF-β – an excellent servant but a bad master

  2012cites this paper
• Cancer Gene Prioritization for Targeted Resequencing Using FitSNP Scores

  2012cites this paper
• Two sides of the story? Smad4 loss in pancreatic cancer versus head‐and‐neck cancer

  2012cites this paper
• Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity

  2012cites this paper
• Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer

  2012cites this paper
• USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor

  2012cites this paper
• Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature

  2012influential citation
• Smad3 regulates E-cadherin via miRNA-200 pathway

  2012influential citation
• DRAK2 participates in a negative feedback loop to control TGF-β/Smads signaling by binding to type I TGF-β receptor.

  2012cites this paper
• TGF-beta antiproliferative effects in tumor suppression Stephan

  2012cites this paper
• TGF-beta antiproliferative effects in tumor suppression.

  2012cites this paper
• Identification of Germline Alterations in the Mad-homology 2 (MH2) Domain of SMAD3 and SMAD4 In Breast Cancer Susceptibility

  2012cites this paper
• Peer Reviewed Title: DRAK2 Participates in a Negative Feedback Loop to Control TGF-β/Smads Signaling by Binding to Type I TGF-β Receptor

  2012cites this paper
• USP4 is regulated by Akt phosphorylation and deubiquitylates TGF-beta type I receptor

  2012cites this paper
• Tumor suppressor genes

  2012cites this paper
• Roles of TGFβ signaling Smads in squamous cell carcinoma

  2011influential citation
• Injectable delivery system of 2-methoxyestradiol for breast cancer therapy using biodegradable thermosensitive poly(organophosphazene) hydrogel

  2011cites this paper
• New reagents for improved in vitro and in vivo examination of TGF-β signalling

  2011cites this paper
• Bone morphogenetic protein and bone metastasis, implication and therapeutic potential.

  2011cites this paper
• Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)

  2011cites this paper
• Comparative effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line.

  2011cites this paper
• Development of a Bayesian Joint Logistic Model to Better Study the Association between Haplotypes and Disease

  2011cites this paper
• Activation of the TGF-β/Smad signaling pathway in oncogenic transformation by v-Rel.

  2011cites this paper
• Genomic profiling combined with gene expression profiling in primary central nervous system lymphoma.

  2011cites this paper
• Smad3 contributes to positioning of proliferating cells in colonic crypts by inducing EphB receptor protein expression.

  2011cites this paper
• Transforming growth factor-β and the hallmarks of cancer.

  2011cites this paper
• The Role of miR-21 and miR-31 in Cellular Responses Mediated by TGF-β: A Dissertation

  2011cites this paper
• Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling

  2010cites this paper
• Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling.

  2010cites this paper
• TGF-beta induces telomerase-dependent pancreatic tumor cell cycle arrest.

  2010cites this paper
• Melatonin and vitamin D3 synergistically down‐regulate Akt and MDM2 leading to TGFβ‐1‐dependent growth inhibition of breast cancer cells

  2010cites this paper
• TGF-β1 interactome: Metastasis and beyond

  2010cites this paper
• Cellular MicroRNAs 200b and 429 Regulate the Epstein-Barr Virus Switch between Latency and Lytic Replication

  2010cites this paper
• Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer

  2010cites this paper
• Smad3 Protein Levels Are Modulated by Ras Activity and during the Cell Cycle to Dictate Transforming Growth Factor-β Responses*

  2009cites this paper
• TGF-β/Smad Signaling in Growth Control of Prostate Epithelial Cells

  2009cites this paper
• Transforming growth factor-beta signaling and tumor angiogenesis.

  2009cites this paper
• Role of the Type III TGF-beta Receptor Cytoplasmic Domain in Breast Cancer Progression

  2009influential citation